Last 12 months
Inside the activity.
0 purchase rows · 65 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 21 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2021 Filed May 14, 2021 20:29 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000079 · wf-form4_162102414232381.xml · derivative · entry 15 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:29 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 400 | $165.26 | $66,105.00 |
DisclosureSEC source: 0001713683-21-000079 · wf-form4_162102414232381.xml · nonDerivative · entry 8 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,192 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F8 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $165.12 to $165.53, inclusive. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:29 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 769 | $164.37 | $126,398.84 |
DisclosureSEC source: 0001713683-21-000079 · wf-form4_162102414232381.xml · nonDerivative · entry 7 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,592 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $163.94 to $164.81, inclusive. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:29 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,062 | $163.32 | $173,450.51 |
DisclosureSEC source: 0001713683-21-000079 · wf-form4_162102414232381.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,361 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $162.89 to $163.61, inclusive. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:29 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 900 | $162.19 | $145,971.00 |
DisclosureSEC source: 0001713683-21-000079 · wf-form4_162102414232381.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,423 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $161.86 to $162.81, inclusive. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:29 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,269 | $161.13 | $365,610.32 |
DisclosureSEC source: 0001713683-21-000079 · wf-form4_162102414232381.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,323 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $160.79 to $161.63, inclusive. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:29 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,100 | $160.26 | $176,286.00 |
DisclosureSEC source: 0001713683-21-000079 · wf-form4_162102414232381.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,592 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $159.78 to $160.57, inclusive. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:29 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 500 | $159.11 | $79,553.00 |
DisclosureSEC source: 0001713683-21-000079 · wf-form4_162102414232381.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,692 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.76 to $159.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (8) to this Form 4. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:29 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000079 · wf-form4_162102414232381.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:13 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000077 · wf-form4_162076396791203.xml · derivative · entry 7 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,834 Underlying: Common Stock · 1,500 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:13 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 40 | $168.34 | $6,733.60 |
DisclosureSEC source: 0001713683-21-000077 · wf-form4_162076396791203.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $168.31 to $168.37, inclusive. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:13 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 300 | $167.31 | $50,192.28 |
DisclosureSEC source: 0001713683-21-000077 · wf-form4_162076396791203.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,803 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $167.01 to $167.81, inclusive. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:13 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 580 | $166.43 | $96,530.85 |
DisclosureSEC source: 0001713683-21-000077 · wf-form4_162076396791203.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,103 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $165.99 to $166.97, inclusive. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:13 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 580 | $165.60 | $96,047.59 |
DisclosureSEC source: 0001713683-21-000077 · wf-form4_162076396791203.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,683 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.97 to $165.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:13 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 1,500 | $5.82 | $8,730.00 |
DisclosureSEC source: 0001713683-21-000077 · wf-form4_162076396791203.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:19 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000075 · wf-form4_161981392244270.xml · derivative · entry 16 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:19 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 116 | $196.00 | $22,736.00 |
DisclosureSEC source: 0001713683-21-000075 · wf-form4_161981392244270.xml · nonDerivative · entry 9 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,192 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:19 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 700 | $193.13 | $135,193.03 |
DisclosureSEC source: 0001713683-21-000075 · wf-form4_161981392244270.xml · nonDerivative · entry 8 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,308 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F8 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $192.72 to $193.45, inclusive. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:19 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 300 | $191.53 | $57,459.99 |
DisclosureSEC source: 0001713683-21-000075 · wf-form4_161981392244270.xml · nonDerivative · entry 7 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,008 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $191.04 to $191.89, inclusive. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:19 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 700 | $189.94 | $132,954.99 |
DisclosureSEC source: 0001713683-21-000075 · wf-form4_161981392244270.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,308 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $189.55 to $190.48, inclusive. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:19 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,200 | $189.05 | $226,857.00 |
DisclosureSEC source: 0001713683-21-000075 · wf-form4_161981392244270.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,008 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $188.52 to $189.42, inclusive. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:19 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 700 | $187.70 | $131,387.97 |
DisclosureSEC source: 0001713683-21-000075 · wf-form4_161981392244270.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,208 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $187.39 to $188.00, inclusive. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:19 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,284 | $186.80 | $426,653.48 |
DisclosureSEC source: 0001713683-21-000075 · wf-form4_161981392244270.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,908 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $186.38 to $187.37, inclusive. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:19 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,000 | $185.86 | $185,859.00 |
DisclosureSEC source: 0001713683-21-000075 · wf-form4_161981392244270.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,192 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.29 to $186.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (8) to this Form 4. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:19 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000075 · wf-form4_161981392244270.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:14 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000073 · wf-form4_161947524856360.xml · derivative · entry 10 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:14 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 719 | $196.11 | $141,001.58 |
DisclosureSEC source: 0001713683-21-000073 · wf-form4_161947524856360.xml · nonDerivative · entry 8 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F8 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $195.74 to $196.67, inclusive. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:14 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 321 | $195.46 | $62,742.37 |
DisclosureSEC source: 0001713683-21-000073 · wf-form4_161947524856360.xml · nonDerivative · entry 7 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,482 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $194.74 to $195.71, inclusive. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:14 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 40 | $193.82 | $7,752.60 |
DisclosureSEC source: 0001713683-21-000073 · wf-form4_161947524856360.xml · nonDerivative · entry 6 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,803 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $193.74 to $193.89, inclusive. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:14 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 40 | $193.15 | $7,726.00 |
DisclosureSEC source: 0001713683-21-000073 · wf-form4_161947524856360.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,843 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $192.72 to $193.58, inclusive. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:14 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 720 | $191.73 | $138,046.18 |
DisclosureSEC source: 0001713683-21-000073 · wf-form4_161947524856360.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,883 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $191.50 to $192.22, inclusive. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:14 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $190.67 | $19,067.00 |
DisclosureSEC source: 0001713683-21-000073 · wf-form4_161947524856360.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,603 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $190.23 to $191.17, inclusive. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:14 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 60 | $189.26 | $11,355.75 |
DisclosureSEC source: 0001713683-21-000073 · wf-form4_161947524856360.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,703 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.17 to $189.395, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (8) to this Form 4. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:14 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 2,000 | $5.82 | $11,640.00 |
DisclosureSEC source: 0001713683-21-000073 · wf-form4_161947524856360.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2021 Filed Apr 15, 2021 22:00 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000071 · wf-form4_161852399705156.xml · derivative · entry 13 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| April 15, 2021 Filed Apr 15, 2021 22:00 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 600 | $196.80 | $118,078.02 |
DisclosureSEC source: 0001713683-21-000071 · wf-form4_161852399705156.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,192 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $196.55 to $197.12, inclusive. Read SEC document |
| April 15, 2021 Filed Apr 15, 2021 22:00 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 3,300 | $195.90 | $646,470.99 |
DisclosureSEC source: 0001713683-21-000071 · wf-form4_161852399705156.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,792 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $195.31 to $196.30, inclusive. Read SEC document |
| April 15, 2021 Filed Apr 15, 2021 22:00 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,500 | $194.72 | $292,075.95 |
DisclosureSEC source: 0001713683-21-000071 · wf-form4_161852399705156.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,092 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $194.25 to $195.23, inclusive. Read SEC document |
| April 15, 2021 Filed Apr 15, 2021 22:00 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,600 | $193.80 | $310,079.04 |
DisclosureSEC source: 0001713683-21-000071 · wf-form4_161852399705156.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,592 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.24 to $194.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4. Read SEC document |
| April 15, 2021 Filed Apr 15, 2021 22:00 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000071 · wf-form4_161852399705156.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 17:59 UTC |
Rajic DaliPres Go-To-Mkt/ Chief Rev Ofcr
|
GrantCommon Stock | 27,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001713683-21-000069 · wf-form4_161852392413693.xml · nonDerivative · entry 1 Rajic Dali · CIK 0001695005 · Pres Go-To-Mkt/ Chief Rev Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,156 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest as follows: (i) 10% of the RSUs vest in four equal quarterly installments beginning on December 15, 2022; (ii) 40% of the RSUs vest in eight equal quarterly installments beginning December 15, 2023 and (iii) 50% of the RSUs vest in eight equal quarterly installments beginning December 15, 2025. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 21:59 UTC |
Schlossman RobertChief Legal Officer
|
GrantCommon Stock | 11,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001713683-21-000070 · wf-form4_161852396721787.xml · nonDerivative · entry 1 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,218 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest as follows: (i) 10% of the RSUs vest in four equal quarterly installments beginning on December 15, 2022; (ii) 40% of the RSUs vest in eight equal quarterly installments beginning December 15, 2023 and (iii) 50% of the RSUs vest in eight equal quarterly installments beginning December 15, 2025. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 17:58 UTC |
CANESSA REMOChief Financial Officer
|
GrantCommon Stock | 13,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001713683-21-000068 · wf-form4_161852389997230.xml · nonDerivative · entry 1 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,719 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest as follows: (i) 10% of the RSUs vest in four equal quarterly installments beginning on December 15, 2022; (ii) 40% of the RSUs vest in eight equal quarterly installments beginning December 15, 2023 and (iii) 50% of the RSUs vest in eight equal quarterly installments beginning December 15, 2025. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:00 UTC |
Sinha AmitDirector · President of R&D and CTO
|
GrantCommon Stock | 27,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001713683-21-000071 · wf-form4_161852399705156.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,192 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest as follows: (i) 10% of the RSUs vest in four equal quarterly installments beginning on December 15, 2022; (ii) 40% of the RSUs vest in eight equal quarterly installments beginning December 15, 2023 and (iii) 50% of the RSUs vest in eight equal quarterly installments beginning December 15, 2025. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 20:16 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000063 · wf-form4_161834500516677.xml · derivative · entry 7 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 20:16 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 442 | $188.85 | $83,471.97 |
DisclosureSEC source: 0001713683-21-000063 · wf-form4_161834500516677.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $188.29 to $189.15, inclusive. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 20:16 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 600 | $187.82 | $112,693.98 |
DisclosureSEC source: 0001713683-21-000063 · wf-form4_161834500516677.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,205 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $187.28 to $188.18, inclusive. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 20:16 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 300 | $186.45 | $55,935.99 |
DisclosureSEC source: 0001713683-21-000063 · wf-form4_161834500516677.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,805 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $186.10 to $186.64, inclusive. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 20:16 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 658 | $185.41 | $122,002.02 |
DisclosureSEC source: 0001713683-21-000063 · wf-form4_161834500516677.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,105 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.60 to $185.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 20:16 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 2,000 | $5.82 | $11,640.00 |
DisclosureSEC source: 0001713683-21-000063 · wf-form4_161834500516677.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.